COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

Study finds that the median length for the antibody half-life immune response was 63 days for the primary series, and increased to...

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

GeoVax to Present at World Vaccine Congress, Thursday April 4th.

Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-CM04S1, the Company’s next-generation non-MRNA Covid-19 vaccine...

IMAC Holdings (BACK) Explodes 94% Higher Post Reverse Split, With 42 Million Shares Trading...

Simply Incredible! 2024 Will be the Year of Post Reverse Split Revenge! Taking advantage of post reverse-split investor...

China Remains at Risk to Future MonkeyPox Outbreaks.

GeoVax (GOVX) intends to become the first U.S.-based supplier of the MVA vaccine to prevent Mpox and smallpox.

GeoVax Live Webcast

Tonight, Monday at 5:30 PM. And You Don't Fly to Newport Beach and Deal With all the Drinking, Investment Bankers, and...

Killer, 44-Page Report on GeoVax (GOVX).

And a Nine-Page Summary Report..Great Weekend Reading. This is one killer report. In fact if we might be so...

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

New report nearly doubles the GeoVax addressable market of Immunocompromised Patients (i.e. potential customers) from 15 Million, to 23 Million patients! Not...

The Extraordinary Dr. Koffman, Who Beat Leukemia.

Dr. Brian Koffman is extraordinary, in many ways. He’s extraordinary in the medical sense because, after twelve years of battling blood...

GeoVax (GOVX) Conference Call at 4:30 ET, the 29th.

GeoVax to Host Conference Call at 4:30 PM ET GeoVax to Report 2023 Financial Results and Provide Corporate...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...